[1] |
Plachouri KM, Georgiou S. Therapeutic approaches to pyogenic granuloma: an updated review[J]. Int J Dermatol, 2019,58(6):642⁃648. doi: 10.1111/ijd.14268.
|
[2] |
Deshpande AJ, Dubey VC. 3% Polidocanol sclerotherapy for pyogenic granuloma: efficacy and safety analysis[J]. J Cutan Aesthet Surg, 2022,15(3):284⁃287. doi: 10.4103/JCAS.JCAS_119_21.
|
[3] |
Dissemond J, Grabbe S. Giant pyogenic granuloma[J]. CMAJ, 2008,178(1):25⁃26. doi: 10.1503/cmaj.070043.
|
[4] |
Wagner G, Abbenseth R, Heine M, et al. Pyogenic granuloma with satellitosis[J]. Hautarzt, 2020,71(3):219⁃222. doi: 10. 1007/s00105⁃019⁃04497⁃y.
|
[5] |
Liu Y, Chen T, Zhang C, et al. Emerging treatments for reactive cutaneous capillary endothelial proliferation[J]. Indian J Dermatol, 2023,68(1):85⁃90. doi: 10.4103/ijd.ijd_505_22.
|
[6] |
Tursen U, Demirkan F, Ikizoglu G. Giant recurrent pyogenic granuloma on the face with satellitosis responsive to systemic steroids[J]. Clin Exp Dermatol, 2004,29(1):40⁃41. doi: 10. 1111/j.1365⁃2230.2004.01451.x.
|
[7] |
Li VW, Li WW, Talcott KE, et al. Imiquimod as an antiangiogenic agent[J]. J Drugs Dermatol, 2005,4(6):708⁃717.
|
[8] |
Ezzell TI, Fromowitz JS, Ramos⁃Caro FA. Recurrent pyogenic granuloma treated with topical imiquimod[J]. J Am Acad Dermatol, 2006,54(5 Suppl):S244⁃245. doi: 10.1016/j.jaad.2005. 04.015.
|
[9] |
Cubiró X, Planas⁃Ciudad S, Garcia⁃Muret MP, et al. Topical timolol for paronychia and pseudopyogenic granuloma in patients treated with epidermal growth factor receptor inhibitors and capecitabine[J]. JAMA Dermatol, 2018,154(1):99⁃100. doi: 10.1001/jamadermatol.2017.4120.
|
[10] |
Filippi F, Patrizi A, Veneziano L. Labial pyogenic granuloma successfully treated with topical timolol in an adult[J]. Dermatol Ther, 2022,35(4):e15307. doi: 10.1111/dth.15307.
|
[11] |
Goetze AC, Sasaya E, Cerci FB, et al. Pyogenic granuloma of the lip with complete resolution after topical propranolol[J]. J Drugs Dermatol, 2019,18(10):1061⁃1062.
|
[12] |
Kesaree N, Babu PS, Banapurmath CR, et al. Umbilical granuloma[J]. Indian Pediatr, 1983,20(9):690⁃692.
|
[13] |
Daruwalla SB, Dhurat RS. A pinch of salt is all it takes! The novel use of table salt for the effective treatment of pyogenic granuloma[J]. J Am Acad Dermatol, 2020,83(2):e107⁃e108. doi: 10.1016/j.jaad.2019.12.013.
|
[14] |
Daruwalla SB, Ghate S, Dhurat R. Establishing the efficacy and safety of the novel use of common salt for the treatment of pyogenic granuloma[J]. Clin Exp Dermatol, 2021,46(7):1243⁃1247. doi: 10.1111/ced.14658.
|
[15] |
Calado R, Calvão J, Pereira S, et al. Pyogenic granuloma: a new therapeutic role for salt?[J]. J Paediatr Child Health, 2021,57(3):459⁃460. doi: 10.1111/jpc.15375.
|
[16] |
Bin Rubaian NF. Complete resolution of a refractory pyogenic granuloma following topical salt treatment[J]. Open Access Emerg Med, 2021,13:445⁃448. doi: 10.2147/OAEM.S323793.
|
[17] |
George NM, Potlapati A. Salt for the treatment of pyogenic granuloma in a patient with pustular psoriasis of palms[J]. Clin Exp Dermatol, 2021,46(2):407⁃409. doi: 10.1111/ced.14368.
|
[18] |
Bernales Salinas A, Toro Sepúlveda A, Meier Pincheira H, et al. Case report: pyogenic granuloma⁃just salt, a simple and pain⁃free treatment[J]. Dermatol Ther, 2022,35(1):e15194. doi: 10. 1111/dth.15194.
|
[19] |
Janyoungsak P, Emrat K, Chatmapanrangsee J, et al. Randomised comparative study on the efficacy of 3% versus 30% NaCl solution in the treatment of umbilical granuloma[J]. J Paediatr Child Health, 2022,58(9):1566⁃1570. doi: 10.1111/jpc.16034.
|